The Emerging Asian Cannabinoid (CBD) Industry
Creating a portfolio of high value diversified operations and assets in the emerging Asian Cannabinoid industry.
CBD Group Asia is a fully integrated investment and distribution company built to capitalize on the next frontier for CBD sector expansion and growth in Asia.
Company Details
- Founded
- -
- Address
- Bellevue Centre 235 – 15th Street, Suite 300,canada
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- http://www.cbdgroup.asia
- HQ
- Vancouver, British Columbia
Cbd Group Asia Questions
Cbd Group Asia's website is http://www.cbdgroup.asia
Cbd Group Asia's LinkedIn profile is https://ca.linkedin.com/company/cbd-group-asia
Cbd Group Asia's industry is
Investment Management
Cbd Group Asia's top competitors are
Swiss Cbd Group,
Hempfy - Premium Swiss Cannabis,
Cannabis Consensus Ch,
Grupo Cannavita,
Phytoxtract,
Enmedify Health,
Swiss Cannabis,
Swiss Medical Cannabis Sa,
Smc Laboratories, Inc.,
Cantopia.eu.
Cbd Group Asia's categories are Investment Management
Cbd Group Asia's founding year is 2019
